Skip to main content
logo
GenEmbryomics Limited (XGEN)
GenEmbryomics was planning to go public, but the IPO was withdrawn on Apr 23, 2025.
IPO Price
$4.75
Shares Offered
1,095,000
Deal Size
$5.20M

GenEmbryomics Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.

Operating Activities

Year Ending
Jun '24 Jun '23
Net Income
-1.98-0.52
Other Operating Activities
0.820.06
Operating Cash Flow
-1.17-0.46
Operating Cash Flow Growth
--

Financing Activities

Year Ending
Jun '24 Jun '23
Share Issuance / Repurchase
0.570.23
Debt Issued / Paid
0.540.26
Financing Cash Flow
1.10.49

Net Cash Flow

Year Ending
Jun '24 Jun '23
Net Cash Flow
-0.070.03

Free Cash Flow

Year Ending
Jun '24 Jun '23
Free Cash Flow
-1.17-0.46
Free Cash Flow Growth
--